英文原著

2020年

  1. Robinson BM, Morgenstern H, Karaboyas A, Li Y, Bieber BA, Hakim R, Hasegawa T, Jadoul M, Schaeffner E, Vanholder R, Pisoni RL, Port FK. Estimating the Fraction of First-year Hemodialysis Deaths Attributable to Potentially Modifiable Risk Factors: Results from the DOPPS.  Clinical Epidemiology. 2020;12:51-60. [PubMed][Fulltext]
  2. Sasaki S, Takada T, Fukuma S, Imamoto M, Hasegawa TNishiwaki H, Iida H, Fukuhara S. Screening tool for identifying adults with excessive salt intake among community dwelling adults: a population-based cohort study. Am J Clin Nutr. 2020;111:814-820. [PubMed][Fulltext]
  3. Ishiwatari A, Yamamoto S, Fukuma S, Hasegawa T, Wakai S, Nangaku M. Changes in Quality of Life in Older Hemodialysis Patients: A Cohort Study on Dialysis Outcomes and Practice Patterns. Am J Nephrol. 2020;51(8):650-658.[PubMed][Fulltext]
  4. Aboulatta L, Sugita H, Wakabayashi H, Noma H, Sasaki T. Comparison of extended versus intermittent infusion of antipseudomonal beta-lactams for the treatment of critically ill patients with respiratory infections: A systematic review and meta-analysis. Int J Infect Dis. 2020;98:41-50. [PubMed][Fulltext]
  5. Usui T, Zhao J, Fuller D, Hanafusa N, Hasegawa T, Fujino H, Nomura T, Zee J, Young E, Robinson BM, Nangaku M. Association of Erythropoietin Resistance and Fibroblast Growth Factor 23 in Dialysis Patients: Results from the J-DOPPS Study. Nephrology. 2020 Aug 3[Epub ahead of print][PubMed][Fulltext]
  6. Nitta K, Goto S, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Wada A, Hamano T, Hoshino J, Joki N, Abe M, Yamamoto K, Nakamoto H. Annual Dialysis Data Report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality. Renal Replacement Therapy. 2020; 6: 41. [Fulltext]
  7. Hoshino J, Abe M, Hamano T, Hasegawa T, Wada A, Ubara Y, Takaichi K, Nakai S, Masakane I, Kosaku N. Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study. BMJ Open Diabetes Research & Care. [in press]
  8. Sukul N, Karaboyas A, Csomor PA, Schaufler T, Wen W, Menzaghi F, Rayner HC, Hasegawa T, Al Salmi I, Al-Ghamdi SMG, Guebre-Egziabher F, Ureña-Torres PA, Pisoni RL. Self-Reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients. Kidney Medicine. [in press]

 

2019年

  1. Nishiwaki H,  Hasegawa T*, Koiwa F, Hamano T, Masakane I (*corresponding author). The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry. PLoS ONE. 2019;14(1):e0210533.[PubMed][Fulltext]
  2. Hasegawa T*, Sakamaki K, Koiwa F, Akizawa T, Hishida A (*corresponding author). Clinical Prediction Models for Progression of Chronic Kidney Disease to End-Stage Kidney Failure under Pre-dialysis Nephrology Care: Results from the Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol. 2019;23(2):189-198. [PubMed][Fulltext].
  3. Maruta Y, Hasegawa T*, Yamakoshi E, Nishiwaki H, Koiwa F, Imai E, Hishida A (*corresponding author). Association between Serum Na-Cl Level and Renal Function Decline in Chronic Kidney Disease: Results from the Chronic Kidney Disease Japan Cohort (CKD-JAC) Study. Clin Exp Nephrol. 2019; 23(2):215-222.  [PubMed][Fulltext]
  4. Iida H, Kurita N, Takahashi S, Sasaki S, Nishiwaki H, Omae K, Yajima N, Fukuma S, Hasegawa T, Fukuhara S. The Sukagawa Study Group. Salt intake and body weight correlate with higher blood pressure in the very elderly population: The Sukagawa study. J Clin Hypertens. 2019;21(7):942-949. [PubMed][Fulltext]
  5. Nishiwaki H, Sasaki S, Hasegawa T*, Sasai F, Kawarazaki H, Minatoguchi S, Uchida D, Koitabashi K, Ozeki T, Koiwa F (*corresponding author). External validation of the quick Sequential Organ Failure Assessment score for mortality and bacteremia risk evaluation in Japanese patients undergoing hemodialysis: A retrospective multi-center cohort study. BMJ Open. 2019;9(7):e028856. [PubMed][Fulltext]
  6. Nitta K, Masakane I, Hanafusa N, Taniguchi M, Hasegawa T, Nakai S, Goto S, Wada A, Hamano T, Hoshino J, Joki N, Abe M,  Yamamoto K, Nakamoto H. Annual Dialysis Data Report 2017, JSDT Renal Data Registry. Renal Replacement Therapy. 2019; 5: 53. [Fulltext]

 

2018年

  1. Hasegawa T*, Nishiwaki H, Ota E, William MM Levack, Noma H. (*corresponding author). Aldosterone antagonists for people with chronic kidney disease requiring dialysis (Protocol). Cochrane Database of Systematic Reviews. 2018, Issue 8. Art. No.: CD013109.[Cochrane][Fulltext]
  2. Nishiwaki H, Fukuma S, Hasegawa T, Kimachi M, Akizawa T, Fukuhara S. Dialysis-related practice patterns among dialysis patients with cancer. Health Sci Rep. 2018: e46.[PubMed][Fulltext]
  3. Nishiwaki HHasegawa T*, Shinji M, Matsuo F, Watanabe T, Makino H, Koiwa F, Hishida A (*corresponding author). Practice pattern of physician's directions of exercise restriction in patients with chronic kidney disease. Results from the Chronic Kidney Disease Japan Cohort study. Clin Exp Nephrol. 2018; 22(5): 1108-1115. [PubMed][Fulltext]
  4. Masakane I, Taniguchi M, Nakai S, Tsuchida K, Goto S, Wada A, Ogata S, Hasegawa T, Hamano T, Hanafusa N, Hoshino J, Minakuchi J,  Nakamoto H. Annual Dialysis Data Report 2015, JSDT Renal Data Registry. Renal Replacement Therapy. 2018; 4: 19. [Fulltext]
  5. Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME. Serum Potassium and the Risk of Adverse Outcomes Across the Range of Kidney Function: A CKD Prognosis Consortium Meta-Analysis. Eur Heart J. 2018;39(17):1535-1542. [PubMed]
  6. Hoshino J, Hamano T, Abe M, Hasegawa T, Wada A, Ubara Y, Takaichi K, Inaba M, Nakai S, Masakane I. Superiority of glycated albumin over hemoglobin A1c in predicting mortality in diabetic hemodialysis patients. Nephrol Dial Transplant. [Epub ahead of print][PubMed]
  7. Nishiwaki H, Hasegawa T*, Ikenoue T, Tominaga N, Yazawa M, Kawarazaki H, Shibagaki Y, Yamamoto Y, Fukuma S, Yamazaki S, Fukuhara S (*corresponding author). Association between post-dialysis hemoglobin level and the survival of vascular access. J Vasc Access. 2018;19(1):69-75. [PubMed][Fulltext]
  8. Okubo K, Uchida E, Terahara T, Akiyama K, Kobayashi S, Tanaka Y. Efficacy and safety of emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis. Allergol Int. [Epub ahead of print].[Fulltext]
  9. Niihata K, Takahashi S, Kurita N, Yajima N, Omae K, Fukuma S, Okano T, Nomoto Y, Omori K, Fukuhara S; Sukagawa Study Group* (*collaborators: Hasegawa T, Iida H, Kobayashi S, Sasaki S, Naganuma T, Nishiwaki H, Tominaga R). Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People: A Cross-Sectional Sukagawa Study. J Am Med Dir Assoc. 2018;19(3):235-239. [PubMed] [Fulltext]
  10. Masakane I, Taniguchi M, Nakai S, Tsuchida K, Wada A, Ogata S, Hasegawa T, Hamano T, Hanafusa N, Hoshino J, Goto S, Yamamot K, Minakuchi J,  Nakamoto H. Annual Dialysis Data Report 2016, JSDT Renal Data Registry. Renal Replacement Therapy. 2018; 4: 45. [Fulltext]

 

2017年

  1. Rayner H, Larkina M, Wang Graham-Brown MM, van der Veer SN, Ecder T, Hasegawa T, Kleophas W, Bieber B, Tentori F, Robinson, Pisoni RL. International comparisons of prevalence, awareness and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017;12(12):2000-2007. [PubMed][Fulltext]
  2. Hasegawa T*, Zhao J, Duller DS, Bieber B, Zee J, Morgenstern H, Hanafusa N, Nangaku M (*corresponding author). Erythropoietin hyporesponsiveness in dialysis patients: possible role of statins. Am J Nephrol. 2017;46(1):11-17. [PubMed[Fulltext] [紹介記事]
  3. Imaizumi T, Hasegawa T, Nomura T, Sasaki S, Nishiwaki H, Ozeki T, Shimizu H, Minatoguchi S, Yamakawa T, Yazawa M, Uchida D, Kawarazaki H, Miyamoto M, Suzuki T, Koitabashi K, Furusho M, Fujita Y. Association between Staphylococcus aureus bacteremia and hospital mortality in hemodialysis patients with bloodstream infection: a multicenter cohort from Japanese tertiary care centers. Ther Apher Dial. 2017;21(4):354-360. [PubMed]
  4. Sasaki S, Hasegawa T*, Kawarazaki H, Nomura A, Uchida D, Imaizumi T, Furusho M, Nishiwaki H, Fukuma S, Shibagaki Y, Fukuhara S (*corresponding author). Development and Validation of a Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient Settings. PLoS ONE. 2017;12(1):e0169975. [PubMed]
  5. Sasaki S, Kawarazaki H, Hasegawa T, Shima H, Naganuma T, Shibagaki Y. Anemia and Long-Term Renal Prognosis in Patients with Post-Renal Acute Kidney Injury of Nonmalignant Cause. Nephron.  2017;135(2):129-136. [PubMed]
  6. Masakane I, Hasegawa T, Ogata S, Kimata N, Nakai S, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. Annual peritoneal dialysis report 2014, the peritoneal dialysis registry. Renal Replacement Therapy. 2017; 3: 21. [Fulltext]
  7. Nitta K, Masakane I, Tomo T, Tsuchida K, Ikeda K, Ogawa T, Kanda E, Kanno Y, Komatsu Y, Taniguchi M, Taki F, Hasegawa T, Hanafusa N, Hamano T, Fukagawa M, MInakuchi J, Yamamoto H, Washida N, Wada T, Watanabe Y. Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy. Renal Replacement Therapy. 2017; 3: 34.  [Fulltext]
  8. Uchida D, Sasaki S, Kawarazaki H, Miyamoto M, Nomura A, Koitabashi K, Nishiwaki H, Shibagaki Y; Japanese InvestigatOrs with Innovative NeTwork about Kidney Disease (JOINT-KD). Systemic Inflammatory Response Syndrome Is Not an Indicator of Bacteremia in Hemodialysis Patients With Native Accesses: A Multicenter Study. ASAIO J. 2017; 63:501-506. [PubMed]
  9. Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner H, Vanholder R, Combe C, Hasegawa T, Finkelstein F, Lopes A, Robinson BM, Pisoni RL, Tentori F. Association between Changes in Quality of Life and Mortality in Hemodialysis Patients: Results from the DOPPS. Nephrol Dial Transplant. 2017;32(3):521-527. [PubMed]

 

2016年

  1. Masakane I, Hasegawa T*, Ogata S, Kimata N, Nakai S, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K (*corresponding author). Peritoneal Dialysis Registry with 2013 Survey Report. Ther Apher Dial. 2016;20(6):557-568. [PubMed]
  2. Yazawa M, Kido R, Seiji O, Hasegawa T, Hanafusa N, Iseki K, Tsubakihara Y, Shibagaki Y. Early mortality was high and strongly associated with functional status in incident Japanese hemodialysis patients: A cohort study of the large national dialysis registry. PLoS ONE. 2016;11(6): e0156951. [PubMed]
  3. Sakao Y, Ojima T, Yasuda H, Hashimoto S, Hasegawa T, Iseki K, Tsubakihara Y, Kato A. Serum creatinine modifies associations between body mass index and mortality and morbidity in prevalent hemodialysis patients. PLoS ONE. 2016;11(3):e0150003. [PubMed]
  4. Akizawa T, Kurita N, Mizobuchi M, Fukagawa M, Onishi Y, Yamaguchi T, Ellis A, Fukuma S, Brookhart A, Hasegawa T, Kurokawa K, Fukuhara S. PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Scientific Reports.  2016;6:19612. [PubMed]
  5. Komukai D, Hasegawa T, Kaneshima N, Takayasu M, Sato Y, Hirose M, Yoshimura Y. Influence of Acute Kidney Injury on the Time to Complete Remission in Adult Minimal Change Nephrotic Syndrome: A Single-Center Study. Nephrology. 2016;21(10):887-892. [PubMed]